Many genetic variants linked to inherited eye disorders rarely lead to disease, meaning up to 2% of people could carry these variants without ever developing vision problems, according to a new s tudy ...

Neuroretinal thickness and macular vessel density decline as part of normal aging, mimicking some signs of glaucoma.

Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. controlThere are no OCU410-related serious ...

An editorial published today in The New England Journal of Medicine (NEJM) writes that Science Corporation's PRIMA implant is the first treatment in clinical trials to successfully restore functional ...

About 10% of the U.S. population fits into the highest-risk category, with a 20% or higher risk of a cardiac event; 54% are ...

Levodopa may reduce the risk of progressing from early to neovascular age-related macular degeneration by targeting GPR143 ...

In advanced dry disease, a key problem is failure of retinal pigment epithelium, often shortened to RPE. These cells help ...

Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with ...

A new study from UCLA Health shows that a cardiovascular risk score already used routinely in primary care can predict who ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...